Erratum: (Arteriosclerosis, Thrombosis, and Vascular Biology (2015) 35 (1945-1953) 10.1161/ATVBAHA.115.305597);Local MicroRNA modulation using a novel Anti-MIR-21-eluting stent effectively prevents experimental in-stent restenosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 9, 2015, Pages 1945-1953

  Wang, Dong ^a,b   Deuse, Tobias ^a,b   Stubbendorff, Mandy ^a,b   Chernogubova, Ekaterina ^c   Erben, Reinhold G ^d   Eken, Suzanne M ^c   Jin, Hong ^c   Li, Yuhuang ^c   Busch, Albert ^c   Heeger, Christian H ^e   Behnisch, Boris ^f   Reichenspurner, Hermann ^a   Robbins, Robert C ^g   Spin, Joshua M ^g,h   Tsao, Philip S ^g,h   Schrepfer, Sonja ^a,b,g   Maegdefessel, Lars ^c  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^e DEPARTMENT OF CARDIOLOGY   (Germany)

^f Translumina GmbH   (Germany)

^g STANFORD UNIVERSITY   (United States)

^h VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

coronary restenosis; hyperplasia; microRNAs; rats; stents

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MICRORNA 21; ANTINUCLEAR ANTIBODY; BIOMATERIAL; MICRORNA; MIRN21 MICRORNA, MOUSE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; EX VIVO STUDY; FLUORESCENCE IMAGING; GENE EXPRESSION; GENE REPRESSION; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; IN-STENT RESTENOSIS; INTERNAL MAMMARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; CORONARY BLOOD VESSEL; CORONARY RESTENOSIS; DISEASE MODEL; DRUG EFFECTS; DRUG ELUTING STENT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GRAFT OCCLUSION, VASCULAR; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; NEOINTIMA; NUDE RAT; PATHOLOGY; PROSTHESIS; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; CELL PROLIFERATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY RESTENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; FEMALE; GENE EXPRESSION REGULATION; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MICRORNAS; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; PROSTHESIS DESIGN; RATS; RATS, NUDE;

EID: 84940398432     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATV.0000000000000024     Document Type: Erratum

References (35)

1. Owens GK, Kumar MS, Wamhoff BR, Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004 84 767 801. doi: 10.1152/physrev.00041.2003
2. Owens GK, Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995 75 487 517
3. Aikawa M, Sakomura Y, Ueda M, Kimura K, Manabe I, Ishiwata S, Komiyama N, Yamaguchi H, Yazaki Y, Nagai R, Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation 1997 96 82 90
4. Yoshida T, Owens GK, Molecular determinants of vascular smooth muscle cell diversity. Circ Res 2005 96 280 291. doi: 10.1161/01.RES.0000155951.62152.2e
5. Deuse T, Hua X, Wang D, Dichloroacetate prevents restenosis in preclinical animal models of vessel injury. Nature 2014 509 641 644. doi: 10.1038/nature13232
6. Bartel DP, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 281 297
7. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C, MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007 100 1579 1588. doi: 10.1161/CIRCRESAHA.106.141986
8. Small EM, Frost RJ, Olson EN, MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010 121 1022 1032. doi: 10.1161/CIRCULATIONAHA.109.889048
9. Maegdefessel L, Spin JM, Adam M, Raaz U, Toh R, Nakagami F, Tsao PS, Micromanaging abdominal aortic aneurysms. Int J Mol Sci 2013 14 14374 14394. doi: 10.3390/ijms140714374
10. Hua X, Deuse T, Michelakis ED, Haromy A, Tsao PS, Maegdefessel L, Erben RG, Bergow C, Behnisch BB, Reichenspurner H, Robbins RC, Schrepfer S, Human internal mammary artery (ima) transplantation and stenting: a human model to study the development of in-stent restenosis. J Vis Exp 2012 e3663. doi: 10.3791/3663
11. Wei Y, Schober A, Weber C, Pathogenic arterial remodeling: the good and bad of microRNAs. Am J Physiol Heart Circ Physiol 2013 304 H1050 H1059. doi: 10.1152/ajpheart.00267.2012
12. Maegdefessel L, Azuma J, Toh R, Deng A, Merk DR, Raiesdana A, Leeper NJ, Raaz U, Schoelmerich AM, McConnell MV, Dalman RL, Spin JM, Tsao PS, MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-Augmented expansion. Sci Transl Med 2012 4 122ra22. doi: 10.1126/scitranslmed.3003441
13. Sirois MG, Simons M, Edelman ER, Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation 1997 95 669 676
14. Alshanwani A, Riches K, Wood I, Turner N, Porter K, 168 exploring the role of microrna-21 on human saphenous vein smooth muscle cell function. Heart 2014 100 Suppl 3 A96
15. Põlajeva J, Swartling FJ, Jiang Y, Singh U, Pietras K, Uhrbom L, Westermark B, Roswall P, miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma. BMC Cancer 2012 12 378. doi: 10.1186/1471-2407-12-378
16. Alfonso F, Byrne RA, Rivero F, Kastrati A, Current treatment of in-stent restenosis. J Am Coll Cardiol 2014;63:2659-2673
17. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C, BASKET-LATE Investigators Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006 48 2584 2591. doi: 10.1016/j.jacc.2006.10.026
18. Townley-Tilson WH, Callis TE, Wang D, MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol 2010 42 1252 1255. doi: 10.1016/j.biocel.2009.03.002
19. Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ, Vinciguerra M, Rosenthal N, Sciacca S, Pilato M, van Heijningen P, Essers J, Brandes RP, Zeiher AM, Dimmeler S, MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 2011 109 1115 1119. doi: 10.1161/CIRCRESAHA.111.255737
20. Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT, Raaz U, Schoelmerich AM, Raiesdana A, Leeper NJ, McConnell MV, Dalman RL, Spin JM, Tsao PS, Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012 122 497 506. doi: 10.1172/JCI61598
21. Boettger T, Beetz N, Kostin S, Schneider J, Krüger M, Hein L, Braun T, Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009 119 2634 2647. doi: 10.1172/JCI38864
22. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D, miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009 460 705 710. doi: 10.1038/nature08195
23. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A, Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009 284 3728 3738. doi: 10.1074/jbc.M808788200
24. Mishra PK, Tyagi N, Kumar M, Tyagi SC, MicroRNAs as a therapeutic target for cardiovascular diseases. J Cell Mol Med 2009 13 778 789. doi: 10.1111/j.1582-4934.2009.00744.x
25. Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, Brown D, Weidhaas JB, Bader AG, Slack FJ, Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 2011 19 1116 1122. doi: 10.1038/mt.2011.48
26. van Rooij E, Olson EN, MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 2012 11 860 872. doi: 10.1038/nrd3864
27. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR, Treatment of HCV infection by targeting microRNA. N Engl J Med 2013 368 1685 1694. doi: 10.1056/NEJMoa1209026
28. Wang M, Li W, Chang GQ, Ye CS, Ou JS, Li XX, Liu Y, Cheang TY, Huang XL, Wang SM, MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol 2011 31 2044 2053. doi: 10.1161/ATVBAHA.111.229559
29. McDonald RA, White KM, Wu J, Cooley BC, Robertson KE, Halliday CA, McClure JD, Francis S, Lu R, Kennedy S, George SJ, Wan S, van Rooij E, Baker AH, miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation. Eur Heart J 2013 34 1636 1643. doi: 10.1093/eurheartj/eht105
30. Chen BX, Ma FY, Luo W, Ruan JH, Xie WL, Zhao XZ, Sun SH, Guo XM, Wang F, Tian T, Chu XW, Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 2008 94 566 570. doi: 10.1136/hrt.2007.118679
31. Gomez IG, MacKenna DA, Johnson BG, Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. J Clin Invest 2015 125 141 156. doi: 10.1172/JCI75852
32. Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R, Yang W, Hou FF, Lan HY, miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 2013 56 663 674. doi: 10.1007/s00125-012-2804-x
33. Zhang A, Liu Y, Shen Y, Xu Y, Li X, miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma. Urology 2011 78 474.e13 474.e19. doi: 10.1016/j.urology.2011.03.030
34. Xu X, Kriegel AJ, Liu Y, Usa K, Mladinov D, Liu H, Fang Y, Ding X, Liang M, Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney Int 2012 82 1167 1175. doi: 10.1038/ki.2012.241
35. Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J, Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A 2010 107 14339 14344. doi: 10.1073/pnas.0912701107